Javascript must be enabled to continue!
Mutant huntingtin fails to directly impair brain mitochondria
View through CrossRef
AbstractAlthough the mechanisms by which mutant huntingtin (mHtt) results in Huntington's disease (HD) remain unclear, mHtt‐induced mitochondrial defects were implicated in HD pathogenesis. The effect of mHtt could be mediated by transcriptional alterations, by direct interaction with mitochondria, or by both. In the present study, we tested a hypothesis that mHtt directly damages mitochondria. To test this hypothesis, we applied brain cytosolic fraction from YAC128 mice, containing mHtt, to brain non‐synaptic and synaptic mitochondria from wild‐type mice and assessed mitochondrial respiration with a Clark‐type oxygen electrode, membrane potential and Ca2+ uptake capacity with tetraphenylphosphonium (TPP+)‐ and Ca2+‐sensitive electrodes, respectively, and, reactive oxygen species production with Amplex Red assay. The amount of mHtt bound to mitochondria following incubation with mHtt‐containing cytosolic fraction was greater than the amount of mHtt bound to brain mitochondria isolated from YAC128 mice. Despite mHtt binding to wild‐type mitochondria, no abnormalities in mitochondrial functions were detected. This is consistent with our previous results demonstrating the lack of defects in brain mitochondria isolated from R6/2 and YAC128 mice. This, however, could be because of partial loss of mitochondrially bound mHtt during the isolation procedure. Consequently, we increased the amount of mitochondrially bound mHtt by incubating brain non‐synaptic and synaptic mitochondria isolated from YAC128 mice with mHtt‐containing cytosolic fraction. Despite the enrichment of YAC128 brain mitochondria with mHtt, mitochondrial functions (respiration, membrane potential, reactive oxygen species production, Ca2+ uptake capacity) remained unchanged. Overall, our results suggest that mHtt does not directly impair mitochondrial functions, arguing against the involvement of this mechanism in HD pathogenesis.
image
Open Science: This manuscript was awarded with the Open Materials BadgeFor more information see: https://cos.io/our-services/open-science-badges/
Title: Mutant huntingtin fails to directly impair brain mitochondria
Description:
AbstractAlthough the mechanisms by which mutant huntingtin (mHtt) results in Huntington's disease (HD) remain unclear, mHtt‐induced mitochondrial defects were implicated in HD pathogenesis.
The effect of mHtt could be mediated by transcriptional alterations, by direct interaction with mitochondria, or by both.
In the present study, we tested a hypothesis that mHtt directly damages mitochondria.
To test this hypothesis, we applied brain cytosolic fraction from YAC128 mice, containing mHtt, to brain non‐synaptic and synaptic mitochondria from wild‐type mice and assessed mitochondrial respiration with a Clark‐type oxygen electrode, membrane potential and Ca2+ uptake capacity with tetraphenylphosphonium (TPP+)‐ and Ca2+‐sensitive electrodes, respectively, and, reactive oxygen species production with Amplex Red assay.
The amount of mHtt bound to mitochondria following incubation with mHtt‐containing cytosolic fraction was greater than the amount of mHtt bound to brain mitochondria isolated from YAC128 mice.
Despite mHtt binding to wild‐type mitochondria, no abnormalities in mitochondrial functions were detected.
This is consistent with our previous results demonstrating the lack of defects in brain mitochondria isolated from R6/2 and YAC128 mice.
This, however, could be because of partial loss of mitochondrially bound mHtt during the isolation procedure.
Consequently, we increased the amount of mitochondrially bound mHtt by incubating brain non‐synaptic and synaptic mitochondria isolated from YAC128 mice with mHtt‐containing cytosolic fraction.
Despite the enrichment of YAC128 brain mitochondria with mHtt, mitochondrial functions (respiration, membrane potential, reactive oxygen species production, Ca2+ uptake capacity) remained unchanged.
Overall, our results suggest that mHtt does not directly impair mitochondrial functions, arguing against the involvement of this mechanism in HD pathogenesis.
image
Open Science: This manuscript was awarded with the Open Materials BadgeFor more information see: https://cos.
io/our-services/open-science-badges/.
Related Results
[RETRACTED] Gro-X Brain Reviews - Is Gro-X Brain A Scam? v1
[RETRACTED] Gro-X Brain Reviews - Is Gro-X Brain A Scam? v1
[RETRACTED]➢Item Name - Gro-X Brain➢ Creation - Natural Organic Compound➢ Incidental Effects - NA➢ Accessibility - Online➢ Rating - ⭐⭐⭐⭐⭐➢ Click Here To Visit - Official Website - ...
Effect of mitochondrial circulation on mitochondrial age density distribution
Effect of mitochondrial circulation on mitochondrial age density distribution
Abstract
Recent publications report that although the mitochondria population in an axon can be quickly replaced by a combination of retrograde and anterograde axon...
Mutant huntingtin does not cross the mitochondrial outer membrane
Mutant huntingtin does not cross the mitochondrial outer membrane
Abstract
Mutant huntingtin (mHTT) is associated with mitochondria, but the exact mitochondrial location of mHTT has not been definitively established. Recently, it w...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
P-791 Supplementation of mitochondria from endometrial mesenchymal stem cells (EnMSCs) improves oocyte quality in aged mice
P-791 Supplementation of mitochondria from endometrial mesenchymal stem cells (EnMSCs) improves oocyte quality in aged mice
Abstract
Study question
To improve the quality of aging oocytes by supplementing the mitochondria from endometrial mesenchymal s...
Abstract 3101: The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model
Abstract 3101: The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model
Abstract
Mutations in isocitrate dehydrogenase (IDH) 1 and 2 are frequently observed in acute myeloid leukemia (AML), glioma, and many other cancers. While wild-type...
Healthy Mitochondria: The Brake of Cell Proliferation of Malignant Melanoma
Healthy Mitochondria: The Brake of Cell Proliferation of Malignant Melanoma
Abstract
Background: Melanoma has become the leading cause of death from skin disease, and male patients show higher mortality rate than female. Mitochondrial transplantati...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...

